https://medicinova.com/mn166/mn-166ibudilastfor-als-international-symposium-on-als-mnd-2021-poster/2025-10-17T12:14:13+09:00https://medicinova.com/mn166/cyclic-amp-elevating-agents-prevent-oligodendroglial-excitotoxicity/2025-10-17T13:09:52+09:00https://medicinova.com/mn166/phosphodiesterase-inhibitors-suppress-il-12-production-with-microglia-and-t-helper-1-development/2025-10-17T13:16:50+09:00https://medicinova.com/mn166/ibudilast-suppresses-tnfalpha-production-by-glial-cells-functioning-mainly-as-type-iii-phosphodiesterase-inhibitor-in-the-cns/2025-10-17T13:16:07+09:00https://medicinova.com/mn166/ibudilast-protects-against-neuronal-damage-induced-by-glutamate-in-cultured-hippocampal-neurons/2025-10-17T13:12:36+09:00https://medicinova.com/mn166/neuroprotective-role-of-phosphodiesterase-inhibitor-ibudilast-on-neuronal-cell-death-induced-by-activated-microglia/2025-10-17T13:18:57+09:00https://medicinova.com/mn166/primary-neuroprotection-the-holy-grail-of-multiple-sclerosis-therapy/2025-10-17T13:20:18+09:00https://medicinova.com/mn166/ibudilast-in-relapsing-remitting-multiple-sclerosis-a-neuroprotectant/2025-10-17T13:21:33+09:00https://medicinova.com/mn166/phase-2-trial-of-ibudilast-in-progressive-multiple-sclerosis/2025-10-17T13:22:40+09:00https://medicinova.com/mn166/mn-166biudilast-for-alcohol-dependence-american-college-of-neuropsychopharmacology-acnp-poster/2025-10-17T13:31:27+09:00https://medicinova.com/mn166/mn-166ibudilast-for-methamphetamine-dependence-college-of-problems-of-drug-dependence-cpdd-poster/2025-10-17T13:36:22+09:00https://medicinova.com/mn166/mn-166ibudilast-for-opioid-dependence-american-academy-of-neurology-aan-poster/2025-10-17T13:39:55+09:00https://medicinova.com/mn166/mn-166ibudilast-for-glioblastoma-american-society-of-clinical-oncology-asco-2017-poster/2025-10-17T13:46:59+09:00https://medicinova.com/mn166/mn-166ibudilast-for-glioblastoma-society-for-neuro-oncology-sno-2023-poster/2025-10-17T13:46:31+09:00https://medicinova.com/mn166/mn-166ibudilast-for-als-international-symposium-on-als-mnd-2017-presentation/2025-10-17T13:50:50+09:00https://medicinova.com/mn166/mn-166ibudilast-for-als-american-academy-of-neurology-aan-2018-poster/2025-10-17T13:54:26+09:00https://medicinova.com/mn166/mn-166ibudilastfor-als-international-symposium-on-als-mnd-2018-presentation/2025-10-17T13:57:31+09:00https://medicinova.com/mn166/mn-166ibudilastfor-als-international-symposium-on-als-mnd-2019-poster/2025-10-17T14:00:36+09:00https://medicinova.com/mn166/mn-166ibudilast-als-webinar/2025-10-17T14:10:07+09:00https://medicinova.com/mn166/mn-166ibudilast-for-progressive-ms-american-academy-of-neurology-aan-2015-poster/2025-10-17T14:31:31+09:00https://medicinova.com/mn166/mn-166ibudilast-for-progressive-ms-sprint-ms-phase-2b-trial-top-line-results-ectrims-2017-presentation/2025-10-17T14:36:56+09:00https://medicinova.com/mn166/mn-166ibudilast-for-progressive-ms-sprint-ms-phase-2b-trial-disability-date-actrims-2018-poster/2025-10-17T14:41:08+09:00https://medicinova.com/mn166/mn-166ibudilast-for-progressive-ms-sprint-ms-phase-2b-trial-aan-2018-presentation/2025-10-17T14:45:41+09:00https://medicinova.com/mn166/mn-166ibudilast-for-progressive-ms-sprint-ms-phase-2b-trial-aan-2019-poster-nfl/2025-10-17T14:50:08+09:00https://medicinova.com/mn166/mn-166ibudilast-for-progressive-ms-sprint-ms-phase-2b-trial-aan-2019-poster-oct-macular-measures/2025-10-17T14:53:14+09:00